Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
48.12
+2.40 (5.25%)
At close: May 20, 2026, 4:00 PM EDT
48.14
+0.02 (0.04%)
Pre-market: May 21, 2026, 4:47 AM EDT

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Product Sales Revenue
2.08B1.82B3.11B
Product Sales Revenue Growth
14.63%-41.52%-53.40%
Grant Revenue
-22.00M37.00M
Grant Revenue Growth
--40.54%-60.64%
Collaboration Revenue
17.00M13.00M48.00M
Collaboration Revenue Growth
30.77%-72.92%-42.17%
Licensing and Royalty Revenue
-11.00M42.00M
Licensing and Royalty Revenue Growth
--73.81%-
Stand-Ready Manufacturing Revenue
100.00M80.00M-
Stand-Ready Manufacturing Revenue Growth
25.00%--
Revenue (Other)
24.00M--
Revenue (Total)
2.23B1.94B3.24B
Revenue (Total) Growth
14.46%-39.93%-52.74%
Updated May 1, 2026. Data Source: Fiscal.ai.